Recent advances in understanding acute respiratory distress syndrome
- PMID: 29568488
- PMCID: PMC5840611
- DOI: 10.12688/f1000research.11148.1
Recent advances in understanding acute respiratory distress syndrome
Abstract
Acute respiratory distress syndrome (ARDS) is characterized by acute diffuse lung injury, which results in increased pulmonary vascular permeability and loss of aerated lung tissue. This causes bilateral opacity consistent with pulmonary edema, hypoxemia, increased venous admixture, and decreased lung compliance such that patients with ARDS need supportive care in the intensive care unit to maintain oxygenation and prevent adverse outcomes. Recently, advances in understanding the underlying pathophysiology of ARDS led to new approaches in managing these patients. In this review, we want to focus on recent scientific evidence in the field of ARDS research and discuss promising new developments in the treatment of this disease.
Keywords: acute respiratory distress syndrome; therapeutic targets; ventilation.
Conflict of interest statement
Competing interests: None of the authors has to declare any conflict of interest with regard to the present F1000 review. Roman Ullrich received funding from Apeptico GmbH (Vienna, Austria) using funds from grant no. 833159 of the Austrian Research Promotion Agency (FFG) to perform a clinical study investigating AP301 (cited in text PMID: 28750677).No competing interests were disclosed.No competing interests were disclosed.
References
-
- Miller EJ, Cohen AB, Matthay MA: Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit Care Med. 1996;24(9):1448–54. - PubMed
-
- Aldridge AJ: Role of the neutrophil in septic shock and the adult respiratory distress syndrome. Eur J Surg. 2002;168(4):204–14. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
